How stem cells ‘choose’ to become either skeletal or smooth muscle revealedNovember 14th, 2007 - 2:03 am ICT by admin
Researchers at the Aab Cardiovascular Research Institute of the University of Rochester School of Medicine and Dentistry and at the University of Texas Southwestern Medical Center say that their finding also suggests that some current cancer treatments may weaken muscle, and that doctors should begin to see whether a previously undetected side effect exists.
During the study, the researchers found that a transcription factor called myocardin-a protein designed to associate with a section of the DNA code and to turn the expression of that gene on or off-might be the master regulator of whether stem cells become skeletal or smooth muscle.
The study, published in the PNAS, is the first to show that Myocardin not only turns on genes that make smooth muscle cells, but it can also turn off genes that make skeletal muscle, making it a bifunctional, developmental switch.
“These findings could eventually lead to stem-cell based therapies where researchers take control of what the stem cell does once implanted through the action of transcription factors like myocardin, unlike current therapies that ‘hope’ the stem cell will take a correct differentiation path to fight disease,” said Dr. Joseph M. Miano, senior author of the paper and associate professor within the Aab Cardiovascular Research Institute at the University of Rochester Medical Center
“More specifically, many diseases are driven by whether stem cells decide to become skeletal muscle, or instead to become part of new blood vessel formation. These discoveries have created a new wing of medical research that seeks to understand the genetic signals that turn on such stem cell replacement programs,” he added.
Researchers at many institutions have been studying the somite, a group of cells in the human foetus known to develop into skeletal muscle.
The research team in Southwestern did cell lineage and tracking studies, which showed them that myocardin is expressed briefly in the somite during development in mice, but then disappears from that region of the foetus.
According to them, the current data leads to the surprising theory that both skeletal and smooth muscle cells come from the same stem cell region. (ANI)
- Molecular 'playbook' to stop heart failure risk factor found - Sep 24, 2010
- 2 cardio proteins pose double whammy in Alzheimer's - Dec 22, 2008
- 2 proteins in cardiovascular system pose a double whammy in Alzheimer''s - Dec 22, 2008
- Genetic switch that increases muscle blood supply identified - Mar 02, 2011
- Pain killers retard recovery from heart attack - Apr 09, 2012
- Transplanted adult stem cells could heal injured hearts - May 08, 2010
- Stem cell advance paves way for novel treatments for brain diseases - Dec 08, 2010
- Rare disease 'paves way for creating stem cells' - Nov 22, 2010
- Israeli scientists open prospect of repairing damaged hearts - May 23, 2012
- Improving treatment and averting heart failure in kids - Apr 24, 2010
- How stem cells shape up to their surroundings - Oct 08, 2010
- Why hypertensive people's BP increases during exercise - Apr 05, 2011
- Fatal lung vascular disease 'caused by silencing of genes' - Jun 08, 2010
- Now, body cells can be regenerated into heart muscles - Aug 06, 2010
- Mother's bone marrow could cure diseases in unborn baby - Jan 19, 2011
Tags: aab, also suggests that, associate, atherosclerosis, cancer, cardiovascular research institute, developmental switch, genes, human foetus, medical center, muscle making, muscle types, new blood, pnas, skeletal muscle, smooth muscle, stem cell, stem cells, therapies, transcription